This article is more than 5 years old. Information may no longer be current.
Could a salt substitution strategy effectively reduce BP? Read the week’s top stories in cardiology
Click Here to Manage Email Alerts
Findings presented at the European Society of Cardiology Congress showed that a population-wide salt substitute strategy in Peru reduced systolic and diastolic BP, and the influenza vaccine was associated with a significantly reduced risk for mortality in patients with hypertension.
These and more were among the top stories in cardiology last week.
Salt substitute reduced hypertension incidence by 55% in Peru
PARIS — A pragmatic population-wide salt substitute strategy implemented in Peru contributed to reductions in both systolic and diastolic BP, especially in participants who were high risk, according to results from a study presented at the European Society of Cardiology Congress. Read more.
Influenza vaccine reduces poor outcomes in hypertension
PARIS — Influenza vaccination is associated with a significantly reduced risk for all-cause mortality, CV mortality and death from acute MI and stroke in patients with hypertension, according to data presented at the European Society of Cardiology Congress. Read more.
ISCHEMIA highlights newly announced AHA late-breaking clinical trials
New data from CV prevention and treatment trials are among the late-breaking clinical trials selected for presentation at the American Heart Association Scientific Sessions from Nov. 16 to 18 in Philadelphia. Read more.
Pre-diagnosis exercise may improve CV outcomes in older breast cancer survivors
Among long term survivors of primary breast cancer, a high level of exercise pre-diagnosis significantly reduced risk for CV events after diagnosis. Read more.
Sacubitril/valsartan beneficial in real-world HFrEF population
PHILADELPHIA — In a real-world population of patients hospitalized for HF with reduced ejection fraction, sacubitril/valsartan was associated with reduced risk for mortality and rehospitalization at 12 months, according to findings presented at the Heart Failure Society of America Scientific Meeting. Read more.